Literature DB >> 24998108

Comparison of bolus and continuous infusion of esmolol on hemodynamic response to laryngoscopy, endotracheal intubation and sternotomy in coronary artery bypass graft.

Esra Mercanooglu Efe1, Basak Atabey Bilgin2, Zekeriyya Alanoglu2, Murat Akbaba2, Cigdem Denker2.   

Abstract

BACKGROUND AND
OBJECTIVE: The aim of this randomized, prospective and double blinded study is to investigate effects of different esmolol use on hemodynamic response of laryngoscopy, endotracheal intubation and sternotomy in coronary artery bypass graft surgery.
METHODS: After approval of local ethics committee and patients' written informed consent, 45 patients were randomized into three groups equally. In Infusion Group; from 10 min before intubation up to 5th minute after sternotomy, 0.5mg/kg/min esmolol infusion, in Bolus Group; 2 min before intubation and sternotomy 1.5mg/kg esmolol IV bolus and in Control Group; %0.9 NaCl was administered. All demographic parameters were recorded. Heart rate and blood pressure were recorded before infusion up to anesthesia induction in every minute, during endotracheal intubation, every minute for 10 minutes after endotracheal intubation and before, during and after sternotomy at first and fifth minutes.
RESULTS: While area under curve (AUC) (SAP×time) was being found more in Group B and C than Group I, AUC (SAP×Tint and Tst) and AUC (SAP×T2) was found more in Group B and C than Group I (p<0.05). Moreover AUC (HR×Tst) was found less in Group B than Group C but no significant difference was found between Group B and Group I.
CONCLUSION: This study highlights that esmolol infusion is more effective than esmolol bolus administration on controlling systolic arterial pressure during endotracheal intubation and sternotomy in CABG surgery.
Copyright © 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Artéria coronária; Bypass graft surgery; Cirurgia de revascularização; Coronary artery; Endotracheal intubation; Esmolol; Hemodinâmica em esternotomia; Intubação endotraqueal; Laringoscopia; Laryngoscopy; Sternotomy hemodynamics

Mesh:

Substances:

Year:  2013        PMID: 24998108     DOI: 10.1016/j.bjane.2013.07.003

Source DB:  PubMed          Journal:  Braz J Anesthesiol


  5 in total

1.  Effect of dexmedetomidine on attenuation of hemodynamic response to intubation, skin incision, and sternotomy in coronary artery bypass graft patients: A double-blind randomized control trial.

Authors:  Manoj Kamal; Deepa Agarwal; Geeta Singariya; Kamlesh Kumari; Bharat Paliwal; Shobha Ujwal
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2020-06-15

2.  Effects of Intravenous and Inhaled Nebulized Lignocaine on the Hemodynamic Response of Endotracheal Intubation Patients: A Randomized Clinical Trial.

Authors:  Abolfazl Jokar; Maryam Babaei; Sahar Pourmatin; Majid Taheri; Amir Almasi-Hashiani; Arash Yazdanbakhsh
Journal:  Anesth Essays Res       Date:  2018 Jan-Mar

3.  Comparison of Esmolol and Dexmedetomidine for Suppression of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation in Adult Patients Undergoing Elective General Surgery: A Prospective, Randomized Controlled Double-blinded Study.

Authors:  Sandeep Sharma; Om Prakash Suthar; M L Tak; Abhilasha Thanvi; Naveen Paliwal; Rakesh Karnawat
Journal:  Anesth Essays Res       Date:  2018 Jan-Mar

4.  The comparison of dexmedetomidine, esmolol, and combination of dexmedetomidine with esmolol for attenuation of sympathomimetic response to laryngoscopy and intubation in patients undergoing coronary artery bypass grafting.

Authors:  Dipali Singh; Sathyanarayan Jagannath; Shio Priye; A Syed Mudassar
Journal:  Ann Card Anaesth       Date:  2019 Oct-Dec

5.  Comparison of Esmolol and Dexmedetomidine Infusion in Attenuating Haemodynamic and Blood Glucose Response to Laryngoscopy and Intubation: A Single Blinded Study.

Authors:  Vincent Koh; Saedah Ali; Mohamad Hasyizan Hassan; Ariffin Marzuki Mokhtar; Mohd Najib Majdi Yaacob; Mohd Zulfakar Mazlan
Journal:  Malays J Med Sci       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.